![]() G1 Therapeutics G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. | ![]() Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. | ![]() Alpine Immune Sciences Alpine Immune Sciences is a biotechnology company that develops protein-based immunotherapies. | |
Founding Date | Founding Date 2008 | Founding Date 1982 | Founding Date 2015 |
Type | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||
Locations | Locations Durham, US HQ | Locations Morris Plains, US HQ | Locations Seattle, US HQ |
Employees | Employees 17015% increase | Employees 8914% decrease | Employees 484% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $82.5m (FY, 2023) | Revenue (est.) $295k (FY, 2019) | Revenue (est.) $58.9m (FY, 2023) |
Cost of goods | Cost of goods $7.2m (FY, 2023) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $75.3m (FY, 2023) | Gross profit $295k (FY, 2019) | Gross profit N/A |
Net income | Net income ($48m) (FY, 2023) | Net income ($357.3m) (FY, 2019) | Net income ($32.2m) (FY, 2023) |
Operating ⚠ | |||
Patents (US) | Patents (US) 40 (FY, 2020) | Patents (US) 405 (Sep, 2022) | Patents (US) N/A |
Funding | |||
Total funding raised | Total funding raised $ 289.6m | Total funding raised $ 30m | Total funding raised $ 49.3m |

Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
View company
Alpine Immune Sciences is a biotechnology company that develops protein-based immunotherapies.
View company